Shaun Holt

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial

Mitesh Patel, Janine Pilcher, Alison Pritchard et al. · The Lancet Respiratory Medicine · 2013 · 209 citations

Pharmacy, Internal Medicine, Pharmacotherapy +16

Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · Diabetes Obesity and Metabolism · 2017 · 186 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma

Thomas Charles, Dean Quinn, Mark Weatherall et al. · Journal of Allergy and Clinical Immunology · 2007 · 170 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +12